Activity value 76united states Buyer&Supplier,Last transaction date:
2025-07-12
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for upm pharmaceuticals inc. from 2023 to 2024.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2024, the company has completed 3 transactions, with a transaction quantity of 0.19 and a transaction weight of 0.
YearTransactionsQuantityWeight
202314120
202430.190
Bill of lading data
<
1/15
>
Trade date
2024/07/02
B/L No.
3228611
Suppliers
msn laboratories private
Buyers
upm pharmaceuticals inc.
POLs
hyderabad air
PODs
newark, nj
Supply area
India
Purchas area
United States
Weight
——
Amount
82600
Hs code
29333990
Product tags
ioi,som,nilotinib,e base
Product description
NILOTINIB FREE BASE REGIOISOMER IMP(QTY:25 MG)
Expand
Trade date
2024/07/02
B/L No.
3228611
Suppliers
msn laboratories private
Buyers
upm pharmaceuticals inc.
upm pharmaceuticals inc. is united states Buyer&Supplier,
and primarily engages in the import and export business of products such as axitinib,vial,analytical standard.
According to the 52wmb.com global trade database, as of 2025-07-12, the company has completed 81 international trades,
with its main trading regions covering india,china,other etc.
The core products include HS29339990,HS29333990,HS300630 etc,
often transported via new york,port savannah ga, port bristol etc,
and its main trading partners are simson pharma,hangzhou alletest biotech co.ltd.,pharmaffiliates analytics synthetics pvt ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on upm pharmaceuticals inc. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.